“Our research program leverages genetic and epidemiological methodologies alongside state-of-the-art technologies and analytical frameworks to investigate the role of human genetic variation in physiological traits and diabetes. Through collaborative efforts within international consortia, and by harnessing the power of large-scale biobanks, population-based cohorts, and well-phenotyped clinical studies, we aim to uncover the genetic basis of diabetes risk, progression, therapeutic response, and complications. Our overarching objective is to enable the development, validation, and implementation of precision medicine approaches in clinical practice—ultimately improving health outcomes and advancing equitable care for individuals living with diabetes.” Aaron Leong, MD, MSc
